Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)
Key Information
Due Date: January 7, 2028
Agency: United States Department of Health and Human Services
Source: Federal
Website: View Website
Funding Categories:
Funding Amount: Not Specified
Funding Type: Grant
Match Required: No
Status: Posted
Contact Info:
grantsinfo@nih.gov
NIH Grants Information grantsinfo@nih.gov
NIH Grants Information grantsinfo@nih.gov
Overview
Through this engineering-oriented Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to encourage submissions of exploratory/developmental Bioengineering Research Grant (EBRG) applications to demonstrate feasibility and potential utility of new capabilities or improvements in quality, speed, efficacy, operability, costs, and/or accessibility of solutions to problems in basic biomedical, pre-clinical, or clinical research, clinical care delivery, or accessibility.
Show More
Additional Info
Posted Date: December 10, 2024
Application Due Date: January 7, 2028
Estimated Award Date: Not Specified
Eligible Applicants:
- County governments
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- State governments
- Small businesses
- Public housing authorities/Indian housing authorities
- City or township governments
- Independent school districts
- Special district governments
- Public and State controlled institutions of higher education
- Native American tribal organizations (other than Federally recognized tribal governments)
- For profit organizations other than small businesses
- Private institutions of higher education
- Others
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Native American tribal governments (Federally recognized)
Apply with Confidence
Our partners at Syncurrent help local governments move from searching to applying. Confirm eligibility, access funding documents, and begin building a complete application in a single secure platform.
